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Objectives: Non-operative management has become the treatment of choice in the majority of liver
injuries. The aim of this study was to assess the changes in primary treatment and outcomes in a single
Dutch Level 1 trauma centre with wide experience in angio-embolisation (AE).
Methods: The prospective trauma registry was retrospectively analysed for 7-year periods before
(Period 1) and after (Period 2) the introduction of AE. The primary outcome was the failure rate of primary
treatment defined as liver injury-related death or re-bleeding requiring radiologic or operative (re)inter-
ventions. Secondary outcomes were liver injury-related intra-abdominal complications.
Results: Despite an increase in high-grade liver injuries, the incidence of primary non-operative man-
agement more than doubled over the two periods, from 33% (20 of 61 cases) in Period 1 to 72% (84 of
116 cases) in Period 2 (P < 0.001). The failure rate of primary treatment in Period 1 was 18% (11/61),
compared with 11% (13/116) in Period 2 (P = 0.21). Complication rates were 23% (14/61) and 16%
(18/116) in Periods 1 and 2, respectively (P = 0.22). Liver-related mortality rates were 10% (6/61) and 3%
(4/116) in Periods 1 and 2, respectively (P = 0.095). The increase in the frequency of non-operative
management was even higher in high-grade injuries, in which outcomes were improved. In high-grade
injuries in Periods 1 and 2, failure rates decreased from 45% (9/20) to 20% (11/55) (P = 0.041), liver-related
mortality decreased from 30% (6/20) to 7% (4/55) (P = 0.019) and complication rates fell from 60% (12/20)
to 27% (15/55) (P = 0.014). Liver infarction or necrosis and abscess formation seemed to occur more
frequently with AE.
Conclusions: Overall, liver-related mortality, treatment failure and complication rates remained constant
despite an increase in non-operative management. However, in high-grade injuries outcomes improved
after the introduction of AE.
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Introduction
The liver is the organ most frequently injured in abdominal
trauma. Over the last two decades, the management of traumatic
liver injuries has changed considerably. Traditionally, surgery was
the treatment of choice for most liver injuries. However, with the
increasingly fast availability of computed tomography (CT) and
modern, minimally invasive, percutaneous interventional tech-
niques such as angio-embolisation (AE), non-operative manage-
ment has evolved as the treatment of choice in both minor and
major liver injuries.1–3 With non-operative management strate-
gies, approximately 70% of all liver injuries can be treated without
increased risk for mortality.4 Many studies have described decreas-
ing mortality rates using this strategy.2–7 However, various other
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studies have meanwhile reported an increase in the incidence of
major complications, such as hepatic necrosis, abscesses or bile
leakage.8–10
In 1999, AE was introduced in the Academic Medical Centre
(AMC), a designated Level 1 trauma centre in the Netherlands.
Since 2002, angiography with or without embolisation has
become an accepted method for the evaluation and treatment of
liver injuries. The aim of this study was to compare the failure
rates of primary treatment before and after the introduction of
angiography in patients with liver injury in the AMC. The effects
on clinical outcomes and complication rates were also assessed.
Materials and methods
Data collection
All patients with liver injuries admitted to the AMC between
January 1995 and December 2008 were identified for review from
the hospital’s prospective trauma registry, the in-hospital infor-
mation system or financial administrative registration. The pro-
spective interventional radiology registry was checked to verify
that no patients were missed. Patients who were initially treated at
other hospitals were excluded from this analysis. Patients who
were primarily evaluated elsewhere (without intervention) and
referred to the AMC for initial treatment were, however, included.
A chart review was performed to collect demographic data,
including age, gender, trauma mechanism and injury severity
score (ISS). Data collection was performed according to a pre-
planned, standardised format. Primary treatment was assessed as
non-operative (observation and/or AE) or surgical exploration.
Potential liver injury-related complications with subsequent inter-
ventions were also recorded. One radiologist (KPvL), with trauma
and vascular interventional experience, re-evaluated all available
admission CT scans and classified liver injury grades according to
American Association for the Surgery of Trauma (AAST) classifi-
cations.11 Grade 1 and 2 injuries were classified as low grade and
Grade 3–5 injuries were designated as moderate to high grade.
Data on the presence of contrast blushes, haemoperitoneum and
the extension of haemoperitoneum were also registered. If no CT
scan was available, injuries were graded according to intraopera-
tive findings or ultrasonographic outcome.
Study periods
Data and outcomes in two periods were compared. These periods
referred to those before (Period 1, 1995–2001) and after (Period 2,
2002–2008) the introduction of AE in the treatment of liver inju-
ries in the AMC, respectively. A total of 186 patients were eligible
for inclusion during the study period. Nine patients were excluded
because initial evaluation and stabilising interventions had been
performed in other hospitals.
Treatment and imaging protocols
In Period 1, the protocol dictated surgical exploration in patients
with a suspicion of moderate to severe liver injury independent of
haemodynamic status. In Period 2, according to the changed pro-
tocol, haemodynamically unstable patients who did not respond
to fluid resuscitation (non-responders) were treated prima-
rily operatively. Operative treatment began with four-quadrant
packing before the structural exploration of the abdomen. If nec-
essary, the Pringle manoeuvre was performed to stop extensive
haemorrhage and gain an overview. Grade 1–3 injuries were
treated with local tamponade, electro-coagulation, local haemo-
static materials (i.e. TachoSil®) or several sutures (monofilament).
Operative treatment of Grade 4 and 5 injuries was dependent on
the stability of the local haemorrhage control measures men-
tioned above, but usually these injuries were packed with several
gauzes for 24–48 h. Resections were preferably not performed in
the acute phase.
In haemodynamically stable patients or transient responders,
management was primarily non-operative. Non-operative man-
agement consisted of observation in the intensive care unit (ICU)
with regular (6-hourly) blood tests on the first day. The length of
ICU observation depended on the clinical and laboratory findings
and varied from 24 h to 72 h. Depending on CT findings (liver
injury combined with contrast blush), an angiography was subse-
quently performed.
In Period 1, a dual-slice, helical CT scanner was used for scan-
ning trauma patients. Slices measuring 5 mm (in increments of
5 mm) were acquired in the arterial (using bolus tracking) and
portal (70 s time delay) phases to detect liver laceration and con-
trast extravasation.
In Period 2, 16-slice and 64-slice CT scanners were available.
The scanning protocol was adapted to allow the acquisition of
3-mm slices (in increments of 2 mm) in the arterial and portal
phases.
The angiography procedure was performed under local anaes-
thesia. Subsequently, the common femoral artery was punctured
prior to the introduction of a 5-Fr sheath. A 5-Fr cobra catheter or
coeliac catheter (Cordis Corp., Johnson & Johnson Co., Miami,
FL, USA) was used for selective catheterisation of the coeliac
trunk. The lacerated branches of the hepatic artery were identified
with digital subtraction angiography. Superselective catheterisa-
tion and embolisation were performed using a 3-Fr microcatheter
(Renegade™; Boston Scientific Corp., Natick, MA, USA) and
0.018-inch microcoils (Boston Scientific Corp.). Occasionally, a
combination of coils and 300–500-m polyvinyl alcohol particles
(Cook Medical, Inc., Bloomington, IN, USA) was used. Contrast
blush was defined as contrast extravasation or pseudoaneurysms.
Study endpoints
The primary outcome was the failure rate of primary treatment.
Failure was defined as death caused by uncontrollable liver haem-
orrhage, or re-bleeding after primary intervention requiring
radiological or operative (re-)interventions. Preplanned second-
look operations to inspect or remove the packing were not con-
sidered to represent failure. Secondary operations performed
within 24 h because of increased haemodynamic instability were
considered to represent failure. Complications were defined as
HPB 351
HPB 2011, 13, 350–355 © 2011 International Hepato-Pancreato-Biliary Association
liver injury-related or intra-abdominal complications, such as
abscess formation, bile leakage, jaundice, liver infarction and liver
necrosis, cholecystitis and fistula formation. Wound infections or
general complications such as pneumonia were not assessed. Sec-
ondary clinical outcome parameters were length of ICU and total
hospital stay, transfusion requirements in the first 48 h and overall
mortality rate. Mortality was classified according to whether it was
caused by liver-related complications or other causes, whether
traumatic or non-traumatic.
Statistics
All continuous variables are presented as medians with interquar-
tile ranges (p25–p75) and were compared using the Mann–
Whitney U-test for two variables or, in contexts with more than
two variables, the Kruskal–Wallis test. Categorical variables were
calculated as percentages and compared using chi-squared analy-
ses and Fisher’s exact test when applicable. Statistical significance
was declared at the 0.05 level. All data were collated and analysed
using spss for Windows, Version 15.0.1 (SPSS, Inc., Chicago, IL,
USA).
Results
Of the 177 patients included in the study, 122 (69%) were male.
The median age of study patients was 29 years (range: 19–38
years). A total of 43 (24%) patients had sustained penetrating
trauma. Median ISS was 22 (range: 10–34) and median liver AAST
Grade was 2 (range: 2–3). The demographic data, severity of
trauma and initial investigations and treatment for Periods 1 and
2 are shown in Table 1.
Table 2 presents clinical outcomes for both periods. In Period 2,
failure and complication rates and liver-related mortality did not
significantly differ from those in Period 1. The only patient in
Period 2 to die of liver failure was not eligible for liver transplan-
tation because of abdominal sepsis.
Table 3 shows the liver injury-related, intra-abdominal compli-
cations occurring during the two periods. Abscess formation
seemed to occur more frequently after AE. In Period 1 more bile
leakage was found after operative interventions. Four operative
interventions in four patients and nine radiographic interventions
in five patients were necessary to resolve complications in Period
1. In Period 2, complications were treated with eight operations in
six patients and 22 percutaneous interventions in 14 patients. Two
Table 2 Clinical outcomes
Period 1 Period 2 P-value
(n = 61) (n = 116)
Length of hospital stay, days,
median (range)
11 (7–20) 10 (4–26) 0.831
ICU stay, days, median (range) 1 (0–6) 2 (0–5) 0.473
PRBC units, median (range) 4 (0–14) 2 (0–8) 0.183
FFP units, median (range) 2 (0–12) 0 (0–4) 0.029
Failure rate, n (%) 11 (18%) 13 (11%) 0.207
Overall mortality, n (%) 16 (26%) 17 (15%) 0.060
Liver-related mortality, n (%) 6 (10%) 4 (3%) 0.095
Uncontrollable
haemorrhage, n (%)
6 (10%) 3 (3%)
Liver failure, n (%) 0 (0%) 1 (1%)
Complication, n (%) 14 (23%) 18 (16%) 0.222
Two or more complications, n (%) 4 (7%) 9 (8%)
ICU, intensive care unit; FFP, fresh frozen plasma; PRBC, packed red
blood cells
Table 1 Demographic data, severity of trauma and initial investigations and treatment
Period 1 Period 2 P-value
(1995–2001) (2002–2008)
Patients, n 61 116
Age, years, median (range) 29 (19–36) 29 (20–41) 0.617
Male, n (%) 44 (72%) 78 (67%) 0.609
Blunt trauma, n (%) 43 (71%) 91 (78%) 0.241
ISS, median (range) 20 (9–34) 22 (11–34) 0.866
Multi-trauma, n (%) 38 (62%) 79 (68%) 0.438
Initial CT scan, n (%) 21 (36%) 89 (77%) <0.001
Injury grade
Low (Grades 1, 2), n (%) 41 (67%) 61 (53%) 0.061
High (Grades 3–5), n (%) 20 (33%) 55 (47%)
Initial treatment
Observation, n (%) 20 (33%) 61 (52%) <0.001
Operative, n (%) 41 (67%) 32 (28%)
Angio-embolisation, n (%) 0 (0%) 23 (20%)
ISS, injury severity score; CT, computed tomography
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patients required a complication-related operation after non-
operative management in Period 2. Just one patient required a
cholecystectomy as a result of liver and gallbladder necrosis after
embolisation. Two other patients managed non-operatively in
Period 2 experienced temporary liver infarction which re-
solved completely without further intervention. Six planned
re-operations were performed for depacking in Period 1, as were
eight in Period 2.
Table 4 shows the injuries divided into low and high AAST
grades by period and compared for primary treatment and out-
comes. In Period 2, more high-grade injuries were treated non-
operatively with equivalent outcomes with respect to liver-related
mortality rate, failure and complication rates. An increase in non-
operative treatment was also seen in low-grade injuries. Although
the complication rates were comparable, the failure rate seemed to
decrease, but without reaching statistical significance.
Table 5 shows specific CT findings of all patients evaluated with
CT in both periods, classified according to primary treatment and
outcomes. Although patients primarily treated with AE had sus-
tained more severe liver injuries with more contrast blushes and
haemoperitoneum detected on CT, equal failure rates were
detected. However, the patient treated non-operatively received
fewer transfusions within the first 24 h compared with the prima-
rily operated group. Thirteen patients were observed despite a
visible contrast blush on CT. Two of these patients (15%) suffered
re-bleeding which was eventually treated successfully with AE.
Table 6 presents the outcomes of primary treatment by injury
grade for both periods. In one of the nine patients with a Grade 3
injury who underwent AE, primary treatment failed, as it did in
one of the six patients with a Grade 4 injury who underwent
AE in Period 2. The one patient with a Grade 5 injury who was
treated non-operatively underwent AE. This patient’s course
was complicated by temporary hepatic ischaemia and abscess for-
mation, which finally resolved completely with non-operative
management.
Discussion
In concordance with recent literature, the present study shows an
important shift in the treatment of choice during the two periods
Table 3 Liver injury-related or intra-abdominal complications
Period 1 Period 2
Observation Operation Observation Operation AE
(n = 20) (n = 41) (n = 61) (n = 32) (n = 23)
Bile leakage, n – 6 1 – 2
Jaundice/liver failure, n 1 – 1 1 –
Necrosis/infarction, n – 1 – 1 3
Abscess, n 1 1 1 1 5
Cholecystitis, n – – – – 1
ACS – – – 1 –
Fistula, n – 1 – – –
(Re-)bleeding, n 2 3 3 8 2
Total, n 4 12 6 12 13
AE, angio-embolisation; ACS, abdominal compartment syndrome fistula: biliary pleural fistula
Table 4 Outcomes per period for low- and high-grade injuries
Low-grade injuries (Grades 1, 2) High-grade injuries (Grades 3–5)
Period 1 Period 2 P-value Period 1 Period 2 P-value
(n = 41) (n = 61) (n = 20) (n = 55)
AAST grade 1 (1–2) 2 (2–2) 0.003 3 (3–4) 3 (3–4) 0.363
Observation 16/41 40/61 0.008 4/20 21/55 0.173
Operation 25/41 14/61 <0.001 16/20 18/55 <0.001
Angio-embolisation 0/41 7/61 0.040 0/20 16/55 0.040
Liver-related mortality 0/41 0/61 NA 6/20 4/55 0.019
Complication 2/41 3/61 1.000 12/20 15/55 0.014
Failure rate 2/41 2/61 1.000 9/20 11/55 0.041
AAST, American Association for the Surgery of Trauma; NA, not applicable
HPB 353
HPB 2011, 13, 350–355 © 2011 International Hepato-Pancreato-Biliary Association
studied. In the first period (1995–2001), primary surgical explo-
ration was performed in more than two-thirds of patients. After
the introduction of AE and endovascular intervention in the
second period (2002–2008), primary operative management was
reduced to one-third of patients, whereas non-operative manage-
ment was successful in the majority of patients. Despite this
increase in the non-operative management rate and notwith-
standing an increase in the severity of injuries, clinical outcomes
did not differ significantly between the two periods. In addition,
some improvements in outcomes were found with respect to the
failure rate of non-operative management, and liver injury-related
mortality and complication rates in high-grade injuries after the
introduction of AE. This shift towards non-operative manage-
ment, especially in higher-grade injuries with better outcomes,
reflects the outcomes described in the literature in recent years,
during which the majority of liver injuries have been managed
successfully with non-operative methods.2–7 One explanation for
the increased success of non-operative management is the con-
tinuous evolution and improvement in imaging and endovascular
techniques. Modern imaging techniques such as thin-slice, multi-
detection CT allow for a detailed overview of the extent of the liver
injury and reveal the presence of active haemorrhage. The provi-
sion of this information allows a more specific treatment to be
devised. Secondly, the introduction of AE allows patients with
specific CT findings to potentially be treated in a minimally inva-
sive manner. Given the availability of AE, trauma surgeons are
more likely to initiate non-operative treatment, even in higher-
grade injuries, because, in the event of failure, intervention in the
form of AE is possible and, in the event of AE failure, surgical
intervention is possible.
The recent literature reveals that the increased use of AE and
decreased mortality rates result in increased frequencies of severe
complications, such as liver necrosis, bile leakage and intra-
abdominal abscesses.6,9,12 The present study showed that abscess
formation and liver infarction or necrosis were more common in
the period after the introduction of AE. However, there was no
increase in radiographically confirmed bile leakage. In general in
Period 2, few complications emerged after non-operative manage-
ment. After angiography, two surgical interventions were required
in two patients and 16 radiological (re-)interventions were needed
in eight patients. The observed re-operation rate of 2% was
acceptable, compared with the complication-related, re-operation
rates of 21–34% described in the literature.8,13
This study has several limitations, most of which relate to the
retrospective analysis of data. Firstly, the two periods compared
here differ in that not only was AE introduced, but other improve-
ments in trauma care also occurred. After Period 1, the AMC
became a dedicated Level 1 trauma centre to which injured
Table 5 Computed tomography (CT) findings, primary treatment and outcomes in the population evaluated with CT
Population evaluated with CT
Observation Angio-embolisation Operation P-value
(n = 59) (n = 22) (n = 30)
Injury severity score 17 (9–27) 27 (22–34) 34 (13–37) 0.001
AAST grade 2 (2–3) 3 (2–4) 2 (2–3) 0.005
Blush present 13/59 15/22 7/30 <0.001
Haemoperitoneum, present 29/59 17/22 20/30 0.058
Haemoperitoneum 3 quadrants 12/59 11/22 18/30 0.001
PRBC 0 (0–2) 5 (3–7) 10 (4–29) <0.001
FFP 0 (0–2) 3 (0–4) 8 (1–29) <0.001
Failure rate 4/59 2/22 6/30 0.158
AAST, American Association for the Surgery of Trauma; FFP, fresh frozen plasma; PRBC, packed red blood cells
Table 6 Failure rate classified according to injury grade
Grade Period 1 Period 2
Non-op, n Failure, n Op, n Failure, n Non-op, n Failure, n Op, n Failure, n
1 9 0 12 1 11 0 3 1
2 7 1 13 0 36 0 11 1
3 2 0 11 6 28 4 13 3
4 2 1 3 0 8 1 4 3
5 0 NA 2 2 1 0 1 0
Total 20 2 41 9 84 5 32 8
Non-op, non-operative primary management; op, operative primary management; NA, not applicable
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patients requiring specialised trauma care were referred. Simulta-
neously, advances in ICU treatment, transfusion and fluid resus-
citation protocols and radiological and surgical techniques during
Period 2 may also have contributed to better outcomes. The con-
tinuous evolution and improvement of imaging techniques may
also cause a bias in the results. Better imaging quality may influ-
ence and increase injury gradations because such imaging pro-
vides more specific details of the injury. However, we tried to
eliminate this bias by re-evaluating all available CT scans. Sec-
ondly, injury characteristics, such as blushes and/or large haemo-
peritoneum, which are suggestive of more severe injury and can be
diagnosed with all types of CT scanner, were diagnosed more
frequently in the second period.
Secondly, the study design prevented any assessment of the
considerations that had led to the decision for non-operative
management. Based on these results, neither the grade of liver
injury nor other specific CT findings seemed to predict the
primary choice of treatment. In the population initially observed,
22% of patients had a contrast blush on CT and 21% had signs of
severe haemoperitoneum. By contrast, patients who were treated
with AE had more CT findings of severe injury than patients who
were primarily operated. In addition, 23% of patients with low-
grade injuries received operative treatment in Period 2. Although
several studies have described the use of flowcharts based on CT
findings to facilitate decision making, the present data on CT
findings and primary treatment showed that other clinical signs or
injuries must have played an important role in treatment plan-
ning. A final limitation of the present study is that the numbers of
patients included were relatively low. Although we found an
overall increase in non-operative management, we also found a
slight but statistically non-significant improvement in clinical
outcomes in the period after the introduction of AE. The relatively
low number of inclusions provides an explanation for this failure
to achieve statistical significance.
Conclusions
Non-operative management of liver injury is currently under-
taken more frequently than in the past, with low failure rates,
despite an increase in the severity of injuries. After the introduc-
tion of AE in the non-operative management protocols in the
AMC, liver-related mortality, treatment failure and complication
rates remained constant despite the increase in non-operative
management. In high-grade injuries, outcomes with respect to
liver injury-related mortality, complication rate and failure of
primary treatment improved after the introduction of AE. Abscess
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